HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹220 Cr | ₹328 Cr | ₹267 Cr | ₹257 Cr | ₹341 Cr |
What is the latest Operating Profit of HIKAL ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹220 Cr |
| Mar2025 | ₹328 Cr |
| Mar2024 | ₹267 Cr |
| Mar2023 | ₹257 Cr |
| Mar2022 | ₹341 Cr |
How is Operating Profit of HIKAL Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹220 Cr | -32.89 | |
| Mar2025 | ₹328 Cr | 23.00 | |
| Mar2024 | ₹267 Cr | 3.86 | |
| Mar2023 | ₹257 Cr | -24.51 | |
| Mar2022 | ₹341 Cr | - | |
Compare Operating Profit of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,869.8 Cr | 3.3% | 9.6% | -15.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,476.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,764.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,423.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,005.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 3.3% |
9.6% |
-15.5% |
| SENSEX | 0.7% |
-3.5% |
-9.2% |
You may also like the below Video Courses